p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  1992-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V80.10.2577.BLOODJOURNAL80102577PMID 1384790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two types of TNF receptors are expressed on human normal and malignant B lymphocytes.

  1991cited by this paper
• Independent regulation of 55‐kDa and 75‐kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes

  1991cited by this paper
• Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils.

  1991cited by this paper
• Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.

  1991cited by this paper
• The two different receptors for tumor necrosis factor mediate distinct cellular responses.

  1991cited by this paper
• Development of immunoassays for the detection of soluble tumour necrosis factor receptors.

  1991cited by this paper
• Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

  1990cited by this paper
• A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

  1990cited by this paper
• Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo

  1990cited by this paper
• Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences.

  1990cited by this paper
• Shedding of tumor necrosis factor receptors by activated human neutrophils

  1990cited by this paper
• A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

  1990cited by this paper
• Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor

  1990cited by this paper
• Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors

  1990cited by this paper
• Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

  1990cited by this paper
• Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

  1990cited by this paper
• Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo.

  1990cited by this paper
• Molecular cloning and expression of a receptor for human tumor necrosis factor.

  1990cited by this paper
• Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

  1990cited by this paper
• Functional properties of CD19 B lymphocytes positively selected from buffy coats by immunomagnetic separation

  1990cited by this paper
• Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

  1990cited by this paper
• Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.

  1989cited by this paper
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

  1989cited by this paper
• Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells

  1988cited by this paper
• Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

  1988cited by this paper
• Effect of tumor necrosis factor alpha on mitogen-activated human B cells

  1987cited by this paper
• Serum-free in vitro bioassay for the detection of tumor necrosis factor.

  1986cited by this paper
• Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices.

  1984cited by this paper

• Importance of TNF-alpha and its alterations in the development of cancers.

  2020cites this paper
• Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role

  2020cites this paper
• Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

  2018cites this paper
• The influence of TNF alpha -308 G/A polymorphism on oxidative stress in patients with chronic lymphocytic leukemia.

  2017cites this paper
• Whole cell-based surface plasmon resonance measurement to assess binding of anti-TNF agents to transmembrane target.

  2016cites this paper
• Czynnik martwicy guza i jego rola w przewlekłej białaczce limfocytowej (PBL)

  2012cites this paper
• leukemia Advances in the biology and treatment of B-cell chronic lymphocytic

  2011cites this paper
• Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

  2011cites this paper
• The exploitation of neuronal survival factors in Burkitt’s lymphoma and germinal centre B cells

  2010cites this paper
• A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease.

  2008cites this paper
• Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen.

  2008cites this paper
• A study on the TNF-α system in Caucasian Spanish patients with alcoholic liver disease

  2008cites this paper
• Polymorphisms of tumor-necrosis factor-α−308 and lymphotoxin-α + 250: Possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells

  2008cites this paper
• Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy

  2008cites this paper
• Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population.

  2005cites this paper
• Immunohistochemical analysis of expression patterns of tumor necrosis factor receptors on lymphoma cells in enzootic bovine leukosis.

  2005cites this paper
• Activation of tumor necrosis factor — α system in HIV-1 infection: Association with markers of immune activation

  2005cites this paper
• The elevation of plasma soluble tumor necrosis factor receptor levels by TNF induction therapy for patients with malignancy

  2005cites this paper
• Imbalance of tumor necrosis factor receptors during progression in bovine leukemia virus infection.

  2005cites this paper
• B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.

  2005cites this paper
• Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies

  2004influential citation
• Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

  2003cites this paper
• The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.

  2002cites this paper
• Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

  2002cites this paper
• The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia

  2002cites this paper
• Tumor necrosis factor alpha and its receptors in experimentally bovine leukemia virus-infected sheep.

  2001cites this paper
• Tumor necrosis factor α and its receptors in experimentally bovine leukemia virus-infected sheep

  2001cites this paper
• The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL).

  2001cites this paper
• High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.

  2001cites this paper
• Host immune responses in the course of bovine leukemia virus infection.

  2001cites this paper
• Molecular mechanisms involved in TNF and gastrin-mediated gene regulation.

  2001cites this paper
• Tumour Necrosis Factor Gene Polymorphisms in Lymphoproliferative Disease

  2000cites this paper
• Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.

  1999cites this paper
• The cellular biology of B-cell chronic lymphocytic leukemia.

  1998cites this paper
• Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections.

  1998cites this paper
• Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia

  1997cites this paper
• Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.

  1997cites this paper
• Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.

  1997cites this paper
• Serum levels of soluble tumor‐necrosis‐factor receptors in patients with benign and malignant HPV‐associated anogenital lesions

  1997cites this paper
• Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells

  1996cites this paper
• High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.

  1996cites this paper
• Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection

  1996cites this paper
• Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.

  1996cites this paper
• Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

  1995cites this paper
• Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

  1995cites this paper
• Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors

  1995cites this paper
• Detection of membrane and soluble interleukin‐6 receptor in lymphoid malignancies

  1995cites this paper
• Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy.

  1995cites this paper
• Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.

  1995cites this paper
• Biopathologic features of Hodgkin's disease.

  1995cites this paper
• Phase I Study of Tumor Necrosis Factor Plus Actinomycin D in Patients with Androgenindependent Prostate Cancer

  1995cites this paper
• Cytokines as tumour markers.

  1995cites this paper
• Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia.

  1995cites this paper
• Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.

  1995cites this paper
• Defects in signal transduction pathways in chronic B lymphocytic leukemia cells.

  1995cites this paper
• TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line

  1994cites this paper
• Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.

  1994cites this paper
• TNF receptors in chronic lymphocytic leukemia.

  1994cites this paper
• [Chronic lymphatic leukemia].

  1994cites this paper
• Effects of soluble interleukin‐1 receptor and tumor‐necrosis factor receptor, respectively, on the IL‐1‐ and TNF‐α‐induced DNA synthesis of acute myeloblastic leukemia blasts in vitro

  1994cites this paper
• Respective effects of soluble interleukin‐1 receptor and tumour necrosis factor receptor on IL‐1 and TNF‐α‐induced DNA synthesis of common acute lymphoblastic leukaemia blasts in vitro

  1994cites this paper
• Cytokines and intracellular signals involved in the regulation of B-CLL proliferation.

  1993cites this paper
• The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay.

  1993cites this paper
• Autocrine and paracrine growth loops in chronic lymphocytic leukemia.

  1993cites this paper
• High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasma.

  1993cites this paper
• Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation.

  1993cites this paper
• Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy.

  1993cites this paper
• Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin‐2, interleukin‐7 and interleukin‐12

  1993cites this paper
• Circulating interleukin‐1 and tumor necrosis factor antagonists in liver disease

  1993cites this paper